Skip to main content
Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · IEX Real-Time Price · USD
1.650
-0.030 (-1.79%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Tilray Brands Revenue

Tilray Brands had revenue of $743.25M in the twelve months ending February 29, 2024, with 24.65% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $188.34M with 29.36% year-over-year growth. In the fiscal year ending May 31, 2023, Tilray Brands had annual revenue of $627.12M, a decrease of -0.20%.

Revenue (ttm)
$743.25M
Revenue Growth
+24.65%
P/S Ratio
1.83
Revenue / Employee
$464,530
Employees
1,600
Market Cap
1.36B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 2023627.12M-1.25M-0.20%
May 31, 2022628.37M115.29M22.47%
May 31, 2021513.09M107.76M26.59%
May 31, 2020405.33M226.02M126.06%
May 31, 2019179.30M136.17M315.73%
Dec 31, 201843.13M22.59M110.00%
Dec 31, 201720.54M7.89M62.43%
Dec 31, 201612.64M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
U.S. Physical Therapy 611.97M
ANI Pharmaceuticals 517.46M
Alphatec Holdings 511.63M
Arcus Biosciences 237.00M
MannKind 224.60M
Schrödinger 188.48M
Nurix Therapeutics 80.89M
Avadel Pharmaceuticals 55.14M
Revenue Rankings

TLRY News

More News